Eli Lilly Corp. buy UBS Group AG
Start price
24.05.23
/
50%
€397.00
Target price
24.05.24
€462.89
Performance (%)
88.34%
End price
25.05.24
€747.70
Summary
This prediction ended on 25.05.24 with a price of €747.70. The BUY prediction by UBS_Group_AG for Eli Lilly Corp. saw massive gains of 88.34%. UBS_Group_AG has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €4.48 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 1.105% | 1.105% | 20.233% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at UBS Group AG from $447.00 to $498.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€537.70
08.08.25
08.08.25
€767.46
08.08.26
08.08.26
49.75%
08.05.26
08.05.26
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24